Xylocaine-mpf With Epi Injection, Solution
Product Images NDC 51662-1550

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Xylocaine-mpf With Epi (NDC 51662-1550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D1 (Description 1)

Chemical structure diagram of the active ingredient in XYLOCAINE-MPF WITH EPI (Lidocaine hydrochloride). The structure includes a benzene ring with two methyl groups and an amide linkage to a diethylamino group, shown along with the hydrochloride component (HCl).*

FDA Label Image

D2 (Description 2)

Chemical structure diagram depicting the molecular formula of the active ingredient in XYLOCAINE-MPF WITH EPI injection solution. The structure includes a benzene ring with hydroxyl groups and an amine-containing side chain, characteristic of the drug's chemical composition.*

FDA Label Image

Logo (Hs Logo)

FDA Label Image

Max Dosage (Max Dosage Table)

A data table showing recommended doses and volumes for Xylocaine-MPF with EPI (lidocaine hydrochloride injection), listed by administration routes such as infiltration, perineural, nerve blocks, spinal anesthesia, and epidural anesthesia. The table includes columns for dose (grams), volume (mL), and total dose (mg) for each route or block type.*

FDA Label Image

Precautions (Precautions)

A table presenting various drug classes and examples within each. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Examples list specific drugs such as lidocaine under Local anesthetics and chloroquine under Antimalarials.*

FDA Label Image

Updated Case

XYLOCAINE-MPF WITH EPINEPHRINE 20 mg/mL injection solution, 20 mL vial, packaged in a case of 25. The label identifies the product as Xylocaine-MPF with epinephrine 1:200,000 (0.0005%) for epidural and nerve block use. Manufactured by HF Acquisition Co LLC in Mukilteo, WA, with NDC 51662-1550-3.*

FDA Label Image

Updated Pouch

Label for XYLOCAINE-MPF WITH EPI injection, solution with epinephrine at 1:200,000 concentration, 20 mg/mL strength in 20 mL vial. Includes NDC 51662-1550-2, lot number, expiration date, and usage instructions for infiltration and nerve block with storage conditions. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*

FDA Label Image

Updated Rfid

XYLOCAINE-MPF WITH EPI injection solution label showing a barcode, product codes, and instruction to refer to the manufacturing package insert. The label includes the manufacturer HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA 98275.*

FDA Label Image

Updated Vial

Label for Xylocaine-MPF with epinephrine Injection, USP 2%, lidocaine HCl and epinephrine at 1:200,000 concentration. The label states 400 mg per 20 mL (20 mg/mL), for infiltration and nerve block including caudal and epidural use. It is a 20 mL single dose vial, methylparaben free, labeled Rx only. Manufacturer is Fresenius Kabi, Lake Zurich, IL. The label includes storage and usage instructions including protection from light and warnings not to autoclave.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.